We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+11.36%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$127M
AUM Growth
+$16.7M
Cap. Flow
+$5.14M
Cap. Flow %
4.03%
Top 10 Hldgs %
25.21%
Holding
124
New
15
Increased
48
Reduced
33
Closed
7

Top Sells

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$1.72M
2
DOC
PHYSICIANS REALTY TRUST
DOC
+$1.19M
3
CATC
CAMBRIDGE BANCORP
CATC
+$1M
4
MMM icon
3M
MMM
+$877K
5
VTRS icon
Viatris
VTRS
+$632K

Sector Composition

Rank Sector Weight
1 Financials 31.62%
2 Healthcare 16.35%
3 Energy 14.17%
4 Consumer Discretionary 10.71%
5 Industrials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBBK icon
1
The Bancorp
TBBK
$2.79B
$6.39M 5.02%
165,805
+3,580
+2% +$134K
NVR icon
2
NVR
NVR
$17.2B
$3.78M 2.97%
540
-3
-0.6% -$18.5K
CVX icon
3
Chevron
CVX
$388B
$3.3M 2.59%
22,124
+2,261
+11% +$342K
TFIN icon
4
Triumph Financial Inc
TFIN
$1.84B
$2.86M 2.24%
35,653
+2,008
+6% +$136K
LEN icon
5
Lennar Class A
LEN
$20.4B
$2.74M 2.15%
18,995
LLY icon
6
Eli Lilly
LLY
$1.07T
$2.73M 2.14%
4,677
+841
+22% +$491K
ABBV icon
7
AbbVie
ABBV
$458B
$2.59M 2.03%
16,692
+350
+2% +$51K
MRK icon
8
Merck
MRK
$324B
$2.5M 1.96%
22,965
+1,732
+8% +$180K
MGM icon
9
MGM Resorts International
MGM
$11.7B
$2.36M 1.85%
52,740
+1,275
+2% +$50K
COP icon
10
ConocoPhillips
COP
$147B
$2.27M 1.78%
19,567
+1,117
+6% +$131K
GE icon
11
GE Aerospace
GE
$367B
$2.27M 1.78%
22,238
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.24M 1.76%
6,274
+1,205
+24% +$423K
VBTX
13
DELISTED
Veritex Holdings
VBTX
$2.08M 1.63%
89,300
+19,085
+27% +$376K
C icon
14
Citigroup
C
$222B
$2.02M 1.58%
39,234
+219
+0.6% +$9.7K
JPM icon
15
JPMorgan Chase
JPM
$939B
$2.01M 1.58%
11,843
+4,825
+69% +$731K
BMY icon
16
Bristol-Myers Squibb
BMY
$127B
$2M 1.57%
39,002
+6,341
+19% +$333K
FANG icon
17
Diamondback Energy
FANG
$57.6B
$1.97M 1.55%
12,725
-783
-6% -$123K
PFE icon
18
Pfizer
PFE
$140B
$1.96M 1.54%
68,144
+18,657
+38% +$564K
IRM icon
19
Iron Mountain
IRM
$38.2B
$1.87M 1.47%
26,687
-90
-0.3% -$5.65K
TROW icon
20
T. Rowe Price
TROW
$25B
$1.86M 1.46%
17,295
+930
+6% +$92.6K
GILD icon
21
Gilead Sciences
GILD
$161B
$1.72M 1.35%
21,288
-180
-0.8% -$14K
CTRA
22
DELISTED
Coterra Energy
CTRA
$1.67M 1.31%
65,585
-260
-0.4% -$6.96K
OMF icon
23
OneMain Financial
OMF
$6.9B
$1.64M 1.29%
33,304
-95
-0.3% -$3.88K
DVA icon
24
DaVita
DVA
$15.1B
$1.64M 1.28%
15,618
+2,496
+19% +$231K
EOG icon
25
EOG Resources
EOG
$78B
$1.62M 1.27%
13,418
-203
-1% -$25.3K

Similar funds

Sippican Capital Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Sippican Capital Advisors held 124 positions worth $127M, up 15% from $111M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sippican Capital Advisors deployed $5.14M of net new capital in Q4 2023, opening 15 new positions and adding to 48 existing holdings. Its largest new stake was Columbia Banking Systems: 30,800 shares worth $822K.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was PHYSICIANS REALTY TRUST, an estimated $1.19M trimmed.

  • Sippican Capital Advisors's largest Q4 2023 buy was Columbia Banking Systems: 30,800 shares worth $822K.
  • Sippican Capital Advisors added most to JPMorgan Chase in Q4 2023, an estimated $731K increase.
  • Sippican Capital Advisors's biggest Q4 2023 reduction was PHYSICIANS REALTY TRUST, cutting an estimated $1.19M.
  • Sippican Capital Advisors fully exited Organon & Co in Q4 2023, selling an estimated $1.72M.
  • Sippican Capital Advisors's ten largest holdings make up 25% of its $127M portfolio in Q4 2023.
  • Sippican Capital Advisors opened 15 new positions and closed 7 in Q4 2023.
  • Sippican Capital Advisors's portfolio value rose 15% quarter-over-quarter to $127M.

Based on Sippican Capital Advisors's 13F filing for Q4 2023, filed 30 Jan 2024.